Eli Lilly
1,246 hedge funds and large institutions have $69.4B invested in Eli Lilly in 2017 Q2 according to their latest regulatory filings, with 79 funds opening new positions, 419 increasing their positions, 496 reducing their positions, and 69 closing their positions.
14% more first-time investments, than exits
New positions opened: 79 | Existing positions closed: 69
0.24% more ownership
Funds ownership: 76.19% → 76.43% (+0.24%)
0% less funds holding
Funds holding: 1,249 → 1,246 (-3)
2% less capital invested
Capital invested by funds: $70.7B → $69.4B (-$1.32B)
8% less funds holding in top 10
Funds holding in top 10: 26 → 24 (-2)
16% less repeat investments, than reductions
Existing positions increased: 419 | Existing positions reduced: 496
29% less call options, than puts
Call options by funds: $371M | Put options by funds: $524M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$752M |
| 2 |
Dodge & Cox
San Francisco,
California
|
+$487M |
| 3 |
Renaissance Technologies
New York
|
+$221M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$131M |
| 5 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$129M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$217M |
| 2 |
TCIM
TIAA CREF Investment Management
New York
|
-$161M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$154M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$134M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$133M |
LLY Hedge Fund Activity: Q2 2017 in Review
1,246 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q2 2017, worth a combined $69.4B — down 1.9% from $70.7B a quarter earlier.
Buyers outnumbered sellers: 79 funds opened new LLY positions and 69 closed out — a net gain of 10 holders — while 419 added to existing stakes and 496 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $752M. The largest seller was Citadel Advisors, cutting an estimated $217M.
- 1,246 institutional investors held Eli Lilly (LLY) as of Q2 2017, down from 1,249 in Q1 2017.
- Funds reported $69.4B of Eli Lilly stock for Q2 2017, down 1.9% quarter-over-quarter.
- 79 funds opened new Eli Lilly positions in Q2 2017 and 69 closed out, a net change of +10 holders.
- The largest Eli Lilly buyer in Q2 2017 was Janus Henderson Group, an estimated $752M added.
- The largest Eli Lilly seller in Q2 2017 was Citadel Advisors, an estimated $217M sold.
Based on aggregated 13F filings for Q2 2017.